In the April issue, the article entitled "Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis: A Preliminary Study," (J Clin Psychopharmacol. 2008;28:210-213), included incorrect rates of response.
On page 211, in the "Results" section, the third sentence of the second paragraph should read:
Forty-three (86%) patients had at least a 20% reduction on PANSS total scores, and 39 (78%) had a reduction of at least 50%.
Emsley R, Medori R, Koen L, et al. Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study. J Clin Psychopharmacol